Morningstar's Biomed-Lublin Wytwornia Surowic i Szczepionek SA Stock Analysis
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Biomed-Lublin Wytwornia Surowic i Szczepionek SA's Company Profile
Biomed-Lublin Wytwornia Surowic i Szczepionek SA is a pharmaceutical company. The company is engaged in the developing products and therapeutic indications and conducting clinical trials in cooperation with scientific and medical centers. Its products include Prescription drugs, Medical products and Report an adverse reaction.
Lublin, 20-029, Poland